You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanoma

Showing 4551 - 4575 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Worldwide (Saxagliptin, Placebo, pioglitazone)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Haleyville, Alabama
  • +132 more
Mar 18, 2015

Melanoma (Skin) Trial run by the NCI (aldesleukin, recombinant fowlpox-tyrosinase vaccine, vaccinia-tyrosinase vaccine)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Malignant Melanoma Stage IV Trial in Dallas (DC Vaccine and Cyclophosphamide)

Completed
  • Malignant Melanoma Stage IV
  • DC Vaccine and Cyclophosphamide
  • Dallas, Texas
    Baylor University Medical Center
Jun 12, 2013

Melanoma Trial in United States (INXN-1001, INXN-3001)

Completed
  • Melanoma
  • Santa Monica, California
  • +7 more
Jul 17, 2013

Melanoma (Skin) Trial run by the NCI (NY-ESO-1 peptide vaccine, aldesleukin)

Completed
  • Melanoma (Skin)
  • NY-ESO-1 peptide vaccine
  • aldesleukin
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, sargramostim)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +4 more
  • Bethesda, Maryland
    Surgery Branch
Jun 19, 2013

Brain and CNS Tumors, Melanoma (Skin), Metastatic Cancer Trial in Boston, Cambridge (boronophenylalanine-fructose complex)

Completed
  • Brain and Central Nervous System Tumors
  • +2 more
  • boronophenylalanine-fructose complex
  • Boston, Massachusetts
  • +1 more
Jun 25, 2013

Renal Transplantation Trial in Basel (Everolimus (RAD001), Calcineurin Inhibitors (CNI), Mycophenolate acid (MPA)/Azathioprine

Completed
Has Results
  • Renal Transplantation
  • Everolimus (RAD001)
  • +3 more
  • Basel, Switzerland
    Novartis
Jan 15, 2015

Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)

Completed
  • Intraocular Melanoma
  • Melanoma (Skin)
  • gp100 antigen
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013

Kidney Cancer, Melanoma (Skin) Trial run by the NCI (denileukin diftitox)

Completed
  • Kidney Cancer
  • Melanoma (Skin)
  • denileukin diftitox
  • Bethesda, Maryland
  • +1 more
Jun 18, 2013

Stage III Melanoma, Stage IV Melanoma Trial in Houston (cilengitide, pharmacological study, laboratory biomarker analysis)

Terminated
  • Stage III Melanoma
  • Stage IV Melanoma
  • Houston, Texas
    M D Anderson Cancer Center
Jun 4, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, incomplete Freund's adjuvant, recombinant tyrosinase-related protein-2)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, gp209-2M antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 19, 2013

Melanoma (Skin) Trial in Cambridge, Sutton (tanespimycin)

Completed
  • Melanoma (Skin)
  • Cambridge, England, United Kingdom
  • +1 more
Jun 25, 2013

Recurrent Melanoma, Stage IV Melanoma Trial in Chicago (tipifarnib, laboratory biomarker analysis)

Completed
  • Recurrent Melanoma
  • Stage IV Melanoma
  • Chicago, Illinois
    Cancer and Leukemia Group B
Jun 4, 2013

Melanoma (Skin) Trial run by the NCI (MART-1 antigen, aldesleukin, gp100 antigen)

Completed
  • Melanoma (Skin)
  • MART-1 antigen
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 17, 2013

Carcinoma, Hepatocellular Trial in Houston (ADI-PEG 20)

Completed
  • Carcinoma, Hepatocellular
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer center
Mar 24, 2015

Melanoma (Skin) Trial in New York (OVA BiP peptide, gp209-2M antigen, recombinant 70-kD heat-shock protein)

Completed
  • Melanoma (Skin)
  • OVA BiP peptide
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 18, 2013

Melanoma (Skin) Trial run by the NCI (aldesleukin, gp100 antigen, incomplete Freund's adjuvant)

Completed
  • Melanoma (Skin)
  • aldesleukin
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jun 18, 2013

Dyskinesias, Parkinson's Disease, Severe Motor Fluctuations Trial in Germany, New Zealand, United States (Levodopa-carbidopa

Completed
Has Results
  • Dyskinesias
  • +2 more
  • Levodopa-carbidopa intestinal gel
  • +3 more
  • Birmingham, Alabama
  • +21 more
Jan 12, 2015

Chemo-refractory Melanoma Trial in Frankfurt/Main (Sunitinib)

Terminated
  • Chemo-refractory Melanoma
  • Frankfurt/Main, Germany
    Krankenhaus Nordwest
Jun 3, 2013

Melanoma (Skin), Solid Tumor Trial in Rochester (recombinant interferon gamma)

Completed
  • Melanoma (Skin)
  • Unspecified Adult Solid Tumor, Protocol Specific
  • recombinant interferon gamma
  • Rochester, New York
    University of Rochester Cancer Center
Jun 5, 2013

Bladder Cancer, Breast Cancer, Carcinoma of Unknown Primary Trial in Lebanon (filgrastim, docetaxel, gemcitabine HCl)

Completed
  • Bladder Cancer
  • +11 more
  • filgrastim
  • +2 more
  • Lebanon, New Hampshire
    Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Cente
Aug 27, 2013

Rheumatoid Arthritis Trial in Germany (rituximab [MabThera/Rituxan], tocilizumab [RoActemra/Actemra])

Completed
Has Results
  • Rheumatoid Arthritis
  • rituximab [MabThera/Rituxan]
  • tocilizumab [RoActemra/Actemra]
  • Aachen, Germany
  • +82 more
Aug 5, 2015

NSCLC Trial in Worldwide (Erlotinib, Placebo)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +294 more
Sep 1, 2015